IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER
Gestational Trophoblastic Tumor
Fred Hutchinson Cancer Centermonoclonal_antibodyPhase 2Dormant
B
61/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 46/ 100
- Competitive Position
- 89/ 100
Competitive context
6 Active assets in the Gestational Trophoblastic Tumor cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
FILGRASTIM Fred Hutchinson Cancer Center | Phase 2 | B |
Amifostine Gynecologic Oncology Group | Phase 3 | B |
MOXIFLOXACIN OHSU Knight Cancer Institute | Phase 3 | B |
TACROLIMUS Case Comprehensive Cancer Center | Phase 2 | B |
Sargramostim Cancer Treatment Centers of America | Phase 2 | B |
View all 25 →
Same molecule, other indications
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →